Brochure
20 Sep 2024

Particle Characterization Unit - CONTRACT PARTICLE ANALYSIS

PDF 5.8 MB

Analytical services for Drug Substance & Drug Product advanced characterization. Nanomol Technologies provides specialized physicochemical characterisation services for the pharma and biotech industry. We are a team of experts in analysing Critical Quality Attributes (CQA) of particulate materials.

Content provided by our supplier

Nanomol Technologies S.L.

  • ES
  • 2022
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Engineering
Primary activities
Analytical Services
Contract Research Organisation
Laboratory Services
Packaging & drug delivery
Technology

Other Content from Nanomol Technologies S.L. (3)

  • News Pilot Plant for the Production of DELOS Nanoformulations

    A significant milestone is on the corner! 

    We are pleased to announce that our GMP pilot plant for the production of DELOS nanoformulations is almost ready!
  • Brochure DELOS Technology Unit - DELOS FORMULATION TECHNOLOGY

    Development and Manufacturing of nanomedicines and tailored drug delivery systems using patented nanoparticles. Nanomol Technologies provides expert and propietary nanoparticle formulation technology from early preclinical development up to the clinical phase for the pharma and biotech industry. Our qualified team holds a vast knowledge in particle engineering and nanomedicine development.
  • Brochure Studies for the nanocharacterization of drug substances, drug products and ingredients.

    We offer complete analytical nanocharacterization studies in order to properly define critical quality attributes (CQAs) of nanopharmaceuticals, drug delivery systems, nanoparticulate materials, cosmetic and food ingredients.

    We are experts in the development of analytical methods at nanoscopic level. We can provide service packages to design and implement analytical tools which enable to measure and monitor the following CQAs and specifications.